CLINICAL_TRIALS
trial_result
· 2024-02-01
Clinical Trial Update: DENdritic Cell Immunotherapy for Mesothelioma [Phase 2, Phase 3]
Summary
A Phase 2/3 clinical trial update for DENdritic Cell immunotherapy in mesothelioma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amphera BV | Conditions: Mesothelioma | Phase 2, Phase 3 | Status: COMPLETED